"Future trial to include roughly same patient population as previous phase III -"
Roughly same number of patients, but FDA has agreed we can limit to patients who have had CLBP for less than 68 months. That is where we saw the best results.. (Before fibrosis sets in, according to SI)
That 68 months was the median for patients in our first phase 3 trial. However, the doctors deemed that to be "forever," and in practice would expect to use our treatment much, much earlier. Definitely before considering surgery, and some insurance plans will entertain surgery as soon as 6 months after other less invasive treatments fail.
- Forums
- ASX - By Stock
- MSB
- Chronic Lower Back Pain - the sleeping giant.
Chronic Lower Back Pain - the sleeping giant., page-155
-
-
- There are more pages in this discussion • 330 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.10 |
Change
0.000(0.00%) |
Mkt cap ! $1.250B |
Open | High | Low | Value | Volume |
$1.09 | $1.13 | $1.08 | $5.380M | 4.893M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 69437 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 19999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 69437 | 1.085 |
21 | 236832 | 1.080 |
7 | 104317 | 1.075 |
11 | 370859 | 1.070 |
2 | 53400 | 1.065 |
Price($) | Vol. | No. |
---|---|---|
1.095 | 19999 | 1 |
1.100 | 35400 | 3 |
1.105 | 32188 | 2 |
1.110 | 42480 | 5 |
1.120 | 97563 | 8 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online